Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

20 August 2014

19 Pages

Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa

,
,
,
,
,
and
Department of Ophthalmology, Second Hospital, Jilin University, Ziqiang Street No. 218, Changchun 130041, Jilin, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.

Abstract

Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by progressive loss of photoreceptors and eventually leads to retina degeneration and atrophy. Until now, the exact pathogenesis and etiology of this disease has not been clear, and many approaches for RP therapies have been carried out in animals and in clinical trials. In recent years, stem cell transplantation-based attempts made some progress, especially the transplantation of bone marrow-derived mesenchymal stem cells (BMSCs). This review will provide an overview of stem cell-based treatment of RP and its main problems, to provide evidence for the safety and feasibility for further clinical treatment.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.